As STR Biotechnologies, we were delighted to participate in the Ozone and Regenerative Therapies Congress. This scientific event, which addressed ozone therapy along with PRP (Platelet Rich Plasma), CGF (Concentrated Growth Factors), PRF (Platelet Rich Fibrin), and stem cell applications, provided an important platform for sharing current developments in the field of regenerative medicine.

During the congress, current scientific data and clinical experiences regarding the biological effects of ozone therapy, the clinical uses of platelet-derived biological products, fibrin-based regenerative therapies, and stem cell applications were evaluated by expert physicians. Furthermore, the multidisciplinary approach to biological treatment approaches used in orthopedics, aesthetic medicine, sports medicine, and other regenerative medicine fields offered participants a comprehensive scientific experience.

As STR Biotechnologies, we continue to support innovative technologies developed in the fields of ozone therapy and regenerative medicine, to share knowledge with healthcare professionals at scientific events, and to contribute to the development of patient-centered biological treatment approaches.